Home >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Product Name Information
  2. GC16278 A-1210477 MCL-1 inhibitor A-1210477  Chemical Structure
  3. GC17513 A-1331852 BCL-XL inhibitor, potent and selective A-1331852  Chemical Structure
  4. GC60544 A-192621 A-192621 is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM. A-192621  Chemical Structure
  5. GC32981 A-385358 A-385358 is a selective inhibitor of Bcl-XL with Kis of 0.80 and 67 nM for Bcl-XL and Bcl-2, respectively. A-385358  Chemical Structure
  6. GC91113 A011

    An inhibitor of ATM kinase

    A011  Chemical Structure
  7. GC11200 A23187

    Calcimycin

    A23187, free acid is a Ca2+ ionophore

    A23187  Chemical Structure
  8. GC42659 A23187 (calcium magnesium salt)

    Calcimycin

    A23187 is a divalent cation ionophore.

    A23187 (calcium magnesium salt)  Chemical Structure
  9. GC35216 AAPK-25 AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, which can cause mitotic delay and arrest cells in a prometaphase, reflecting by the biomarker histone H3Ser10 phosphorylation and followed by a surge in apoptosis. AAPK-25 targets Aurora-A, -B, and -C with Kd values ranging from 23-289 nM, as well as PLK-1, -2, and -3 with Kd values ranging from 55-456 nM. AAPK-25  Chemical Structure
  10. GC13805 Abacavir Abacavir  Chemical Structure
  11. GC64674 ABBV-167 ABBV-167 is a phosphate prodrug of the BCL-2 inhibitor venetoclax. ABBV-167  Chemical Structure
  12. GC73269 ABBV-467 ABBV-467 is a selective MCL-1 inhibitor (Ki: <0.01 nM). ABBV-467  Chemical Structure
  13. GC42677 ABO (hydrochloride) ABO is a modulator of annexin A7. ABO (hydrochloride)  Chemical Structure
  14. GC60548 ABT-100 ABT-100 is a potent, highly selective and orally active farnesyltransferase inhibitor. ABT-100 inhibits cell proliferation (IC50s of 2.2 nM, 3.8 nM, 5.9 nM, 6.9 nM, 9.2 nM, 70 nM and 818 nM for EJ-1, DLD-1, MDA-MB-231, HCT-116, MiaPaCa-2, PC-3, and DU-145 cells, respectively), increases apoptosis and decreases angiogenesis. ABT-100 possesses broad-spectrum antitumor activity. ABT-100  Chemical Structure
  15. GC14069 ABT-199

    GDC 0199, Venetoclax

    Venetoclax (ABT-199, GDC-0199) is a selective inhibitor of Bcl-2 with a K i of 0.01 nM in cell-free assays. ABT-199  Chemical Structure
  16. GC12405 ABT-263 (Navitoclax)

    Navitoclax,ABT-263,ABT263,ABT 263

    ABT-263 (Navitoclax) is a inhibitor of Bcl-xL, Bcl-2 and Bcl-w, with Ki ≤0.5 nM, ≤1 nM and ≤1 nM respectively. ABT-263 (Navitoclax)  Chemical Structure
  17. GC49745 ABT-263-d8

    Navitoclax-d8

    ABT-263-d8 is the deuterium labeled Navitoclax. Navitoclax (ABT-263) is a potent and orally active Bcl-2 family protein inhibitor that binds to multiple anti-apoptotic Bcl-2 family proteins, such as Bcl-xL, Bcl-2 and Bcl-w, with a Ki of less than 1 nM. ABT-263-d8  Chemical Structure
  18. GC70733 ABT-510 acetate ABT-510 acetate is an anti-angiogenic TSP peptide (Thrombospondin-1 analogue) that induces apoptosis and inhibits ovarian tumour growth in an orthotopic, syngeneic model of epithelial ovarian cancer. ABT-510 acetate  Chemical Structure
  19. GC17234 ABT-737

    ABT 737, ABT737

    An inhibitor of anti-apoptotic Bcl-2 proteins ABT-737  Chemical Structure
  20. GC90489 AC 187 (trifluoroacetate salt)

    An antagonist of calcitonin and amylin receptors

    AC 187 (trifluoroacetate salt)  Chemical Structure
  21. GC40122 Ac-AAVALLPAVLLALLAP-DEVD-CHO (trifluoroacetate salt)

    Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Glu-Val-Asp-CHO, Ac-AAVALLPAVLLALLAP-DEVD-aldehyde, Ac-AAVALLPAVLLALLAPDEVD-CHO, Caspase-3 Inhibitor I, DEVD-CHO-CPP 32

    Ac-AAVALLPAVLLALLAP-DEVD-CHO is a composite of Ac-DEVD-CHO, a peptide inhibitor of caspase-3 and -7, and a cell-permeable hydrophobic sequence derived from K-FGF. Ac-AAVALLPAVLLALLAP-DEVD-CHO (trifluoroacetate salt)  Chemical Structure
  22. GC40118 Ac-AAVALLPAVLLALLAP-IETD-CHO (trifluoroacetate salt)

    Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-CHO, Caspase-8 Inhibitor I

    Ac-AAVALLPAVLLALLAP-IETD-CHO is a composite of Ac-IETD-CHO, a peptide inhibitor of caspase-8, and a cell-permeable hydrophobic sequence derived from K-FGF. Ac-AAVALLPAVLLALLAP-IETD-CHO (trifluoroacetate salt)  Chemical Structure
  23. GC40123 Ac-AAVALLPAVLLALLAP-VAD-CHO (trifluoroacetate salt)

    Caspase Inhibitor II, Ac-AAVALLPAVLLALLAP-VAD-aldehyde, Ac-AAVALLPAVLLALLAPVAD-CHO

    Ac-AAVALLPAVLLALLAP-VAD-CHO is a composite of Ac-VAD-CHO, a non-selective caspase inhibitor, and a cell-permeable hydrophobic sequence derived from K-FGF. Ac-AAVALLPAVLLALLAP-VAD-CHO (trifluoroacetate salt)  Chemical Structure
  24. GA20494 Ac-Asp-Glu-Val-Asp-pNA

    Ac-Asp-Glu-Val-Asp-pNA

    The cleavage of the chromogenic caspase-3 substrate Ac-DEVD-pNA can be monitored at 405 nm. Ac-Asp-Glu-Val-Asp-pNA  Chemical Structure
  25. GC17602 Ac-DEVD-AFC

    N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-Trifluoromethylcoumarin,Caspase-3 Substrate (Fluorogenic)

    fluorogenic substrate for activated caspase-3 Ac-DEVD-AFC  Chemical Structure
  26. GC32695 Ac-DEVD-CHO Ac-DEVD-CHO is a Caspase-3 inhibitor with an IC50 value of 0.016μM. Ac-DEVD-CHO  Chemical Structure
  27. GC48470 Ac-DEVD-CHO (trifluoroacetate salt)

    N-Ac-Asp-Glu-Val-Asp-CHO

    A dual caspase3/caspase7 inhibitor Ac-DEVD-CHO (trifluoroacetate salt)  Chemical Structure
  28. GC10951 Ac-DEVD-CMK

    Ac-Asp-Glu-Val-Asp-CMK,Caspase-3 Inhibitor III

    cell-permeable, and irreversible inhibitor of caspase Ac-DEVD-CMK  Chemical Structure
  29. GC48430 Ac-DEVD-CMK (trifluoroacetate salt)

    AcAspGluValAspCMK, Caspase3 Inhibitor III

    Ac-DEVD-CMK (trifluoroacetate salt)  Chemical Structure
  30. GC68600 Ac-DEVD-CMK TFA

    Caspase-3 Inhibitor III TFA

    Ac-DEVD-CMK (Caspase-3 Inhibitor III) TFA is a selective and irreversible inhibitor of caspase-3. Ac-DEVD-CMK TFA significantly inhibits apoptosis induced by high levels of glucose or 3,20-dibenzoate (IDB; 5). Ac-DEVD-CMK TFA can be used in various experimental methods to inhibit cell apoptosis.

    Ac-DEVD-CMK TFA  Chemical Structure
  31. GC42687 Ac-DMQD-AMC (trifluoroacetate salt)

    Ac-Asp-Met-Gln-Asp-AMC, Ac-Asp-Met-Gln-Asp-7-amino-4-methylcoumarin

    Ac-DMQD-AMC is a fluorogenic substrate for caspase-3. Ac-DMQD-AMC (trifluoroacetate salt)  Chemical Structure
  32. GC42688 Ac-DMQD-CHO (trifluoroacetate salt)

    Ac-Asp-Met-Gln-Asp-CHO, Caspase-3 Inhibitor

    Ac-DMQD-CHO is a peptide inhibitor of caspase-3 (IC50 = 39 nM). Ac-DMQD-CHO (trifluoroacetate salt)  Chemical Structure
  33. GC42689 Ac-DNLD-AMC

    Ac-Asp-Asn-Leu-Asp-MCA, N-Acetyl-Asp-Asn-Leu-Asp-7-amido-Methylcoumarin, Caspase-3 Substrate

    Ac-WLA-AMC is a fluorogenic substrate of caspase-3. Ac-DNLD-AMC  Chemical Structure
  34. GC40154 Ac-ESMD-CHO (trifluoroacetate salt)

    Ac-Glu-Ser-Met-Asp-CHO

    Ac-ESMD-CHO is an inhibitor of caspase-3 maturation. Ac-ESMD-CHO (trifluoroacetate salt)  Chemical Structure
  35. GC65107 Ac-FEID-CMK TFA Ac-FEID-CMK TFA is a potent zebrafish-specific GSDMEb-derived peptide inhibitor. Ac-FEID-CMK TFA  Chemical Structure
  36. GC60558 Ac-FLTD-CMK Ac-FLTD-CMK, a gasdermin D (GSDMD)-derived inhibitor, is a specific inflammatory caspases inhibitor. Ac-FLTD-CMK  Chemical Structure
  37. GC49704 Ac-FLTD-CMK (trifluoroacetate salt)

    Ac-Phe-Leu-Thr-Asp-CMK

    An inhibitor of caspase-1, -4, -5, and -11 Ac-FLTD-CMK (trifluoroacetate salt)  Chemical Structure
  38. GC40152 Ac-IEPD-pNA (trifluoroacetate salt)

    Ac-Ile-Glu-Pro-Asp-p-nitroanilide, Caspase-8 Chromogenic Substrate, Granzyme B Substrate VIII

    Ac-IEPD-pNA is a colorimetric substrate for granzyme B and caspase-8. Ac-IEPD-pNA (trifluoroacetate salt)  Chemical Structure
  39. GC40164 Ac-IETD-CHO (trifluoroacetate salt)

    Caspase-8 Inhibitor

    Ac-IETD-CHO is an inhibitor of caspase-8 (IC50 = 5 nM).

    Ac-IETD-CHO (trifluoroacetate salt)  Chemical Structure
  40. GC42708 Ac-LEHD-AFC (trifluoroacetate salt)

    N-Acetyl-Leu-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase-9 substrate (Fluorogenic)

    Ac-LEHD-AFC is a fluorogenic substrate that can be cleaved by caspase-4, -5, and -9. Ac-LEHD-AFC (trifluoroacetate salt)  Chemical Structure
  41. GC18226 Ac-LEHD-AMC (trifluoroacetate salt)

    Ac-Leu-Glu-His-Asp-AMC, Caspase-9 Substrate

    Ac-LEHD-AMC (trifluoroacetate salt) is a fluorogenic substrate for caspase-9 (Excitation: 341 nm; Emission: 441 nm). Ac-LEHD-AMC (trifluoroacetate salt)  Chemical Structure
  42. GC46791 Ac-LEHD-pNA (trifluoroacetate salt)

    Ac-Leu-Glu-His-Asp-pNA, Caspase-9 Chromogenic Substrate I

    A neuropeptide with diverse biological activities Ac-LEHD-pNA (trifluoroacetate salt)  Chemical Structure
  43. GC40556 Ac-LETD-AFC

    NAcetylLeuGluThrAsp7amino4Trifluoromethylcoumarin, Caspase8 Substrate (Fluorogenic)

    Ac-LETD-AFC is a fluorogenic substrate that can be cleaved specifically by caspase-8. Ac-LETD-AFC  Chemical Structure
  44. GC42709 Ac-LEVD-CHO (trifluoroacetate salt)

    Ac-Leu-Glu-Val-Asp-CHO, Caspase-4 Inhibitor I

    Ac-LEVD-CHO is a caspase-4 inhibitor.

    Ac-LEVD-CHO (trifluoroacetate salt)  Chemical Structure
  45. GC13400 Ac-VDVAD-AFC

    N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin Caspase-2 Substrate (Fluorogenic)

    Ac-VDVAD-AFC is a caspase-specific fluorescent substrate. Ac-VDVAD-AFC can measure caspase-3-like activity and caspase-2 activity and can be used for the research of tumor and cancer. Ac-VDVAD-AFC  Chemical Structure
  46. GC52372 Ac-VDVAD-AFC (trifluoroacetate salt)

    N-Acetyl-Val-Asp-Val-Ala-Asp-AFC, N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase-2 Substrate (Fluorogenic)

    A fluorogenic substrate for caspase-2 Ac-VDVAD-AFC (trifluoroacetate salt)  Chemical Structure
  47. GC42716 Ac-VDVAD-pNA (trifluoroacetate salt)

    Ac-Val-Asp-Val-Ala-Asp-pNA, Caspase-2 Chromogenic Substrate, acetyl-Val-Asp-Val-Ala-Asp-p-nitroanilide, acetyl-VDVAD-p-nitroanilide

    Ac-VDVAD-pNA is a colorimetric substrate for caspase-2. Ac-VDVAD-pNA (trifluoroacetate salt)  Chemical Structure
  48. GC48974 Ac-VEID-AMC (ammonium acetate salt)

    NAcetylValGluIleAsp7amido4Methylcoumarin, Caspase6 Substrate (Fluorogenic)

    A caspase-6 fluorogenic substrate Ac-VEID-AMC (ammonium acetate salt)  Chemical Structure
  49. GC42718 Ac-VEID-CHO (trifluoroacetate salt)

    Ac-Val-Glu-Ile-Asp-CHO

    Ac-VEID-CHO is an inhibitor of caspase-6 (IC50 = 16.2 nM). Ac-VEID-CHO (trifluoroacetate salt)  Chemical Structure
  50. GC70289 AC-VEID-CHO TFA AC-VEID-CHO (TFA) is a peptide-derived caspase inhibitor and has potency of inhibition for Caspase-6, Caspase-3 and Caspase-7 with IC50 values of 16.2 nM, 13.6 nM and 162.1 nM, respectively. AC-VEID-CHO TFA  Chemical Structure
  51. GC40162 Ac-VEID-pNA (trifluoroacetate salt)

    Ac-Val-Glu-Ile-Asp-pNA, Ac-Val-Glu-Ile-Asp-p-nitroanilide, Caspase-6 Chromogenic Substrate

    Ac-VEID-pNA is a substrate for caspase-6. Ac-VEID-pNA (trifluoroacetate salt)  Chemical Structure
  52. GC74380 Ac-VRPR-AMC TFA Ac-VRPR-AMC TFA is a fluorogenic metacaspase substrate. Ac-VRPR-AMC TFA  Chemical Structure
  53. GC40124 Ac-WEAD-AMC (trifluoroacetate salt)

    Ac-Trp-Glu-Ala-Asp-AMC

    Ac-WEAD-AMC is a fluorogenic substrate for caspase-1 and caspase-4. Ac-WEAD-AMC (trifluoroacetate salt)  Chemical Structure
  54. GC42719 Ac-WEAD-pNA (trifluoroacetate salt)

    Ac-Trp-Glu-Ala-Asp-pNA, Ac-Trp-Glu-Ala-Asp-p-nitroanilide, Caspase-1 and Caspase-4 Chromogenic Substrate

    Ac-WEAD-pNA is a colorimetric substrate for caspase-1 and caspase-4. Ac-WEAD-pNA (trifluoroacetate salt)  Chemical Structure
  55. GC46796 Ac-WEHD-AFC (trifluoroacetate salt)

    N-Acetyl-Trp-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase1 Substrate (Fluorogenic), Caspase5 Substrate (Fluorogenic)

    A neuropeptide with diverse biological activities Ac-WEHD-AFC (trifluoroacetate salt)  Chemical Structure
  56. GC68621 Ac-WEHD-AFC TFA

    Ac-WEHD-AFC TFA is a fluorescent substrate for caspase-1. It can detect the fluorescence activity of caspase-1 and is used in research on tumors and inflammation.

    Ac-WEHD-AFC TFA  Chemical Structure
  57. GC18021 Ac-YVAD-CHO

    Caspase-1 Inhibitor I, L 709049, N-Ac-Tyr-Val-Ala-Asp-CHO

    Selective inhibitor of interleukin-1β converting enzyme (ICE; Caspase-1) Ac-YVAD-CHO  Chemical Structure
  58. GC42721 Ac-YVAD-CMK

    N-Ac-Tyr-Val-Ala-Asp-CMK

    Ac-YVAD-CMK is a selective irreversible inhibitor of caspase-1 (Ki=0.8nM), which can prevent the proinflammatory cytokine IL-1β activation. Ac-YVAD-CMK can reduce the inflammatory response and induce a long-lasting neuroprotective effect. Ac-YVAD-CMK  Chemical Structure
  59. GC74500 Acasunlimab

    GEN1046

    Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab  Chemical Structure
  60. GC35227 ACBI1 ACBI1 is a potent and cooperative SMARCA2, SMARCA4 and PBRM1 degrader with DC50s of 6, 11 and 32 nM, respectively. ACBI1 is a PROTAC degrader. ACBI1 shows anti-proliferative activity. ACBI1 induces apoptosis. ACBI1  Chemical Structure
  61. GN10341 Acetate gossypol Acetate gossypol  Chemical Structure
  62. GC11786 Acetylcysteine

    N-acetylcysteine; N-acetyl-L-cysteine; NAC; Acetadote

    Acetylcysteine is the N-acetyl derivative of CYSTEINE. Acetylcysteine  Chemical Structure
  63. GC17094 Acitretin

    all-trans Acitretin, Ro 10-1670, Ro 10-1670/000

    Metabolite of etretinate

    Acitretin  Chemical Structure
  64. GC35242 Actein Actein is a triterpene glycoside isolated from the rhizomes of Cimicifuga foetida. Actein suppresses cell proliferation, induces autophagy and apoptosis through promoting ROS/JNK activation, and blunting AKT pathway in human bladder cancer. Actein has little toxicity in vivo. Actein  Chemical Structure
  65. GC16866 Actinomycin D

    Cosmegen, Dactinomycin, Meractinomycin, NCI C04682, NSC 3053, Oncostatin K

    Actinomycin D (dactinomycin) is a natural chromopeptide isolated from Streptomyces species, and has one heterocyclic chromophore and two cyclic pentapeptide lactone rings. [1] Actinomycin D  Chemical Structure
  66. GC70584 Actinomycin X2 Actinomycin X2 (Actinomycin V), produced by many Streptomyces sp. Actinomycin X2  Chemical Structure
  67. GC16350 Actinonin

    (-)-Actinonin,Ro 06-1467

    Peptidomimetic antibiotic that inhibits aminopeptidases

    Actinonin  Chemical Structure
  68. GC16362 AD57 (hydrochloride) polypharmacological cancer therapeutic that inhibits RET. AD57 (hydrochloride)  Chemical Structure
  69. GC34214 Adalimumab (Anti-Human TNF-alpha, Human Antibody) Adalimumab (Anti-Human TNF-alpha, Human Antibody) is one of the leading therapies for the treatment of rheumatoid arthritis. Adalimumab (Anti-Human TNF-alpha, Human Antibody)  Chemical Structure
  70. GC10610 Adapalene

    CD 271

    RARβ and RARγ agonist Adapalene  Chemical Structure
  71. GC46798 Adapalene-d3 An internal standard for the quantification of adapalene Adapalene-d3  Chemical Structure
  72. GC13959 Adarotene

    ST1926

    An atypical retinoid Adarotene  Chemical Structure
  73. GC74501 Adebrelimab

    SHR-1316

    Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab  Chemical Structure
  74. GC65880 ADH-6 TFA ADH-6 TFA is a tripyridylamide compound. ADH-6 abrogates self-assembly of the aggregation-nucleating subdomain of mutant p53 DBD. ADH-6 TFA targets and dissociates mutant p53 aggregates in human cancer cells, which restores p53's transcriptional activity, leading to cell cycle arrest and apoptosis. ADH-6 TFA has the potential for the research of cancer diseases. ADH-6 TFA  Chemical Structure
  75. GC42735 Adipostatin A

    NSC 776, 5-pentadecyl Resorcinol

    Adipostatin A (Adipostatin A) is a glycerol-3-phosphate dehydrogenase (GPDH) inhibitor with an IC50 of 4.1 μM. Adipostatin A  Chemical Structure
  76. GC11892 AEE788 (NVP-AEE788)

    NVP-AEE788

    AEE788 (NVP-AEE788) is an inhibitor of the EGFR and ErbB2 with IC50 values of 2 and 6 nM, respectively. AEE788 (NVP-AEE788)  Chemical Structure
  77. GC42743 AEM1 Cancer cell survival appears partly dependent on antioxidative enzymes, whose expression is regulated by the Keap1-Nrf2 pathway, to quench potentially toxic reactive oxygen species generated by their metastatic transformation. AEM1  Chemical Structure
  78. GC72386 Afelimomab Afelimomab (MAK 195F) is an anti-tumor necrosis factor F(ab')2 monoclonal antibody fragment. Afelimomab  Chemical Structure
  79. GC13168 AG 825

    Tyrphostin AG825

    Selective ErbB2 inhibitor AG 825  Chemical Structure
  80. GC13697 AG-1024

    AGS 200, Tyrphostin AG1024

    AG-1024 is a reversible, competitive and selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 value of 7µM. AG-1024 can inhibit the phosphorylation of insulin receptor (IR) with an IC50 value of 57µM. AG-1024  Chemical Structure
  81. GC17881 AGK 2 AGK2 is a selective SIRT2 inhibitor, with an IC50 of 3.5 µM. AGK2 inhibits SIRT1 and SIRT3 with IC50 of 30 and 91 µM, respectively. AGK 2  Chemical Structure
  82. GC39584 AGN194204

    IRX4204; NRX194204; VTP 194204

    AGN194204 (IRX4204) is an orally active and selective RXR agonist with Kd values 0.4 nM, 3.6 nM and 3.8 nM and EC50s of 0.2 nM, 0.8 nM and 0.08 nM for RXRα, RXRβ and RXRγ, respectively. AGN194204  Chemical Structure
  83. GC16120 AI-3 Nrf2/Keap1 and Keap1/Cul3 interaction inhibitor AI-3  Chemical Structure
  84. GC46821 Ajoene A disulfide with diverse biological activities Ajoene  Chemical Structure
  85. GC68632 AK-778-XXMU

    AK-778-XXMU is an effective inhibitor of DNA binding 2 (ID2) antagonist, with a KD of 129 nM. AK-778-XXMU can inhibit the migration and invasion of glioma cell lines, induce apoptosis, and more importantly, slow down tumor growth.

    AK-778-XXMU  Chemical Structure
  86. GC39620 AKOS-22 AKOS-22  Chemical Structure
  87. GC11589 AKT inhibitor VIII A potent inhibitor of Akt1 and Akt2 AKT inhibitor VIII  Chemical Structure
  88. GC35275 AKT-IN-3 AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1, Akt2 and Akt3, respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1, P70S6K, and SGK. AKT-IN-3 (compound E22) induces apoptosis and inhibits metastasis of cancer cells. AKT-IN-3  Chemical Structure
  89. GC19897 Albendazole Sulfone

    ABZ-SO2, ABZ-SOO

    Analytical Standards

    Albendazole Sulfone  Chemical Structure
  90. GC49773 Albendazole sulfone-d3

    ABZ-SO2-d3, ABZ-SOO-d3

    An internal standard for the quantification of albendazole sulfone Albendazole sulfone-d3  Chemical Structure
  91. GC48848 Albendazole-d7

    ABZ-d7

    An internal standard for the quantification of albendazole Albendazole-d7  Chemical Structure
  92. GC41080 Albofungin

    Antibiotic P42-1, Antibiotic P42-C

    Albofungin is a xanthone isolated from A. Albofungin  Chemical Structure
  93. GC16597 Alda 1

    ALDH2 activator

    Alda 1  Chemical Structure
  94. GC73642 ALK-IN-26 ALK-IN-26 is an ALK inhibitor with IC50 value of 7.0 μM for ALK tyrosine kinase. ALK-IN-26  Chemical Structure
  95. GC35288 Alkannin

    (-)-Alkannin, NSC 94524

    A naphthoquinone with diverse biological activities Alkannin  Chemical Structure
  96. GC40094 all-trans Retinoic Acid-d5

    atRA-d5, RA-d5, Vitamin A Acid-d5

    all-trans Retinoic acid-d5 is intended for use as an internal standard for the quantification of all-trans retinoic acid by GC- or LC-MS. all-trans Retinoic Acid-d5  Chemical Structure
  97. GC49393 all-trans-13,14-Dihydroretinol A metabolite of all-trans retinoic acid all-trans-13,14-Dihydroretinol  Chemical Structure
  98. GC32127 Alofanib (RPT835)

    RPT835

    Alofanib (RPT835) (RPT835) is a potent and selective allosteric inhibitor of fibroblast growth factor receptor 2 (FGFR2). Alofanib (RPT835)  Chemical Structure
  99. GC14314 Aloperine An alkaloid Aloperine  Chemical Structure
  100. GC35306 alpha-Mangostin alpha-Mangostin (α-Mangostin) is a dietary xanthone with broad biological activities, such as antioxidant, anti-allergic, antiviral, antibacterial, anti-inflammatory and anticancer effects. It is an inhibitor of mutant IDH1 (IDH1-R132H) with a Ki of 2.85 μM. alpha-Mangostin  Chemical Structure
  101. GC18437 Alternariol monomethyl ether

    AME, NSC 638262

    Alternariol monomethyl ether, isolated from the roots of Anthocleista djalonensis (Loganiaceae), is an important taxonomic marker of the plant species. Alternariol monomethyl ether  Chemical Structure

Items 201 to 300 of 2711 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction